A
Andlauer Healthcare Group Inc
TSX:AND
Andlauer Healthcare Group Inc
TSX:AND
Price:
54.97
CAD
0.02%
Market Cap:
CA$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
CA |
|
Wilhelmina International Inc
NASDAQ:WHLM
|
US |
|
Umicore SA
OTC:UMICY
|
BE |
|
Iss A/S
CSE:ISS
|
DK |
|
Accent Group Ltd
ASX:AX1
|
AU |
|
Alzamend Neuro Inc
NASDAQ:ALZN
|
US |
|
V
|
Velo3D Inc
NYSE:VLD
|
US |
|
N
|
National United Resources Holdings Ltd
HKEX:254
|
HK |
|
ROK Resources Inc
XTSX:ROK
|
CA |
|
Mahindra Lifespace Developers Ltd
NSE:MAHLIFE
|
IN |
|
A-Mark Precious Metals Inc
NASDAQ:AMRK
|
US |
|
Minmetals Development Co Ltd
SSE:600058
|
CN |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
C
|
Canada Goose Holdings Inc
SWB:1GC
|
CA |
|
V
|
Vodafone Group PLC
OTC:VODPF
|
UK |
Relative Value
The Relative Value of one AND stock under the Base Case scenario is hidden CAD. Compared to the current market price of 54.97 CAD, Andlauer Healthcare Group Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AND Relative Value
HIDDEN
Multiples Across Competitors
AND Competitors Multiples
Andlauer Healthcare Group Inc Competitors
Andlauer Healthcare Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
2.2B CAD | 3.3 | 31.9 | 13.4 | 23.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
92.5B USD | 0.2 | 51.9 | 13.5 | 13.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 13.1 | 7.7 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
70B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.9B EUR | 1.1 | 19.8 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.3B EUR | 1.1 | 22.8 | 8.8 | 16.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 24.9 | 12 | 17.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 1.9 | 21.7 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.6B EUR | 0.5 | 10.9 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | 11.1 | -26.2 | -28.7 | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14.1 | 7.2 | 9.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
